SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)] [amend]
SEC Accession No. 0001354488-13-004683
Filing Date
2013-08-15
Accepted
2013-08-15 16:24:22
Documents
10
Period of Report
2013-06-30
Filing Date Changed
2013-08-15

Document Format Files

Seq Description Document Type Size
1 CELLULAR BIOMEDICINE GROUP, INC. JUNE 30, 2013 10-Q cbmg_10q.htm 10-Q/A 42074
2 CERTIFICATION cbmg_ex311.htm EX-31.1 15441
3 CERTIFICATION cbmg_ex312.htm EX-31.2 15048
4 CERTIFICATION cbmg_ex321.htm EX-32.1 8036
  Complete submission text file 0001354488-13-004683.txt   7357979

Data Files

Seq Description Document Type Size
5 cmbg-20130630.xml EX-101.INS 944628
6 cmbg-20130630.xsd EX-101.SCH 47968
7 cmbg-20130630_cal.xml EX-101.CAL 62058
8 cmbg-20130630_def.xml EX-101.DEF 98035
9 cmbg-20130630_lab.xml EX-101.LAB 257567
10 cmbg-20130630_pre.xml EX-101.PRE 207411
Mailing Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301
Business Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301 (650) 566-5064
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-52282 | Film No.: 131042493
SIC: 6199 Finance Services
Assistant Director 7